A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types

por Huber, Bettina, Schellenbacher, Christina, Jindra, Christoph, Fink, Dieter, Shafti-Keramat, Saeed, Kirnbauer, Reinhard
Publicado 2015

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)

por Huber, Bettina, Schellenbacher, Christina, Shafti-Keramat, Saeed, Jindra, Christoph, Christensen, Neil, Kirnbauer, Reinhard
Publicado 2017

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses

por Schellenbacher, Christina, Kwak, Kihyuck, Fink, Dieter, Shafti-Keramat, Saeed, Huber, Bettina, Jindra, Christoph, Faust, Helena, Dillner, Joakim, Roden, Richard B.S., Kirnbauer, Reinhard
Publicado 2013